Content
All Posts > Content under Pharma/Biotech
The “New Year” Starts With A Rally
Article By:
Lance Roberts
Read
Saturday, January 5, 2019 6:12 PM EDT
While, at this point, the risk/reward for traders remains on the “bullish” side, the economic warnings from Fed Ex, Apple, and the economic surveys should not be dismissed.
Week In Review: 2018 Results: China Life Science Investment Hits Record Levels
Article By:
ChinaBio® Today
Read
Saturday, January 5, 2019 4:28 PM EDT
Investments in China life science set new records in all categories during 2018, reflecting the increasing development of the industry. And these numbers are spectacular even in comparison to an already strong 2017.
The Top Stocks On The Dow Jones
Article By:
Mat Litalien
Read
Friday, January 4, 2019 7:25 PM EDT
What are the top ranked stocks on the Down Jones Industrial Average? At StockTrades we rank them on key growth, safety and valuation metrics.
In this article: , BA, UNH, WBA Also: AXP, CAT, CVX, DIS, GS, HD, IBM, JNJ, JPM, KO, MCD, MMM, MRK, NKE, PFE, PG, UTX, V, VZ, WMT, XOM, AAPL, CSCO, INTC, MSFT, DWDP, DJI
Cannabis Stock Sector Confirms Its Bull Market As 2019 Kicks Off
Article By:
Taki Tsaklanos
Read
Thursday, January 3, 2019 9:17 AM EDT
It may have been an amazing first trading day for cannabis stocks but this in and on itself does not mean anything. We have to watch the long-term trends.
In this article: CGC
Bristol-Myers To Buy Celgene; A $74 Billion Deal
Article By:
TalkMarkets DailyTalk
Read
Thursday, January 3, 2019 7:31 AM EDT
Bristol-Myers Squibb has struck a deal to buy Celgene in a deal valued at $74 billion in equity and cash.
Biotech Bonanza: 2019 Outlook
Article By:
Tarun Chandra, CFA
Read
Tuesday, January 1, 2019 1:04 PM EDT
In 2019 biotech stocks will have an uphill battle, but will still provide opportunities for attractive gains.
In this article: IBB, SPY, XBI, XLV, MRNA, TSRO Also: AGN, BMY, JNJ, MRK, NVS, PFE, AMGN, LLY, AZN, GSK, ALXN, REGN, CVS, ESRX, VRTX
Verastem, De Risked?
Article By:
Zion Miller
Read
Monday, December 31, 2018 4:11 PM EDT
VSTM has been pushed down for several reasons and was further damaged with the recent unfortunate bearish markets.
In this article: VSTM
Week In Review: Shanghai Industrial To Start $7.3 Billion Biomedical Fund In 2019
Article By:
ChinaBio® Today
Read
Saturday, December 29, 2018 4:08 PM EDT
Shanghai Industrial Investment, a state-owned conglomerate, plans to launch a $7.3 billion equity fund for China biopharma investments. The company plans to begin raising $1.5 billion in January for the fund's first tranche.